Severe hypomagnesemia induced by pentamidine.
The use of pentamidine for treating Pneumocystis carinii pneumonia in AIDS patients has increased the awareness of pentamidine-induced adverse reactions. We report a case of severe hypomagnesemia and concurrent hypocalcemia that occurred during therapy with intravenous pentamidine. Pentamidine therapy was subsequently changed to the nebulized route. Electrolyte imbalances were corrected after daily supplementation with high doses of magnesium and calcium. Clinicians should monitor for electrolyte imbalances which can be severe in patients receiving prolonged courses of pentamidine therapy.
Burnett
R J
RJ
Department of Pharmacy, Saint Francis Hospital, Blue Island, IL 60406.
Reents
S B
SB
D000163:Acquired Immunodeficiency Syndrome / Q000150:complications; D000280:Administration, Inhalation; D006801:Humans; D006996:Hypocalcemia / Q000139:chemically induced / Q000503:physiopathology; D007275:Injections, Intravenous; D008275:Magnesium Deficiency / Q000139:chemically induced* / Q000503:physiopathology; D008297:Male; D008875:Middle Aged; D010419:Pentamidine / Q000008:administration & dosage / Q000009:adverse effects* / Q000627:therapeutic use; D011020:Pneumonia, Pneumocystis / Q000188:drug therapy / Q000209:etiology; D014883:Water-Electrolyte Imbalance / Q000139:chemically induced / Q000503:physiopathology
D010419:Pentamidine